Neoantigen Targeted Therapies, 2019-2030
Roots Analysis is pleased to announce the publication of its recent study, titled, "Neoantigen Targeted Therapies, 2019-2030."
By: Roots Analysis
§ A detailed assessment of the current market landscape of developers engaged in the development of neoantigen targeted therapies.
§ Detailed profiles of developers of neoantigen targeted therapies (shortlisted on the basis of the number of pipeline products).
§ A detailed publication analysis of close to 300 peer-reviewed, scientific articles published during the period 2015-2019 (till February), highlighting the research focus within the industry.
§ An in-depth analysis of the various patents that have been filed / granted related to neoantigens.
§ An analysis of the various partnerships pertaining to neoantigen targeting therapies.
§ An analysis of the investments made at various stages of development in companies that are focused on developing neoantigen targeted therapies.
§ A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
• Target Disease Indication
§ Bone and Cartilage Cancer
§ Colorectal Cancer
§ Head and Neck Cancer
§ Renal Carcinoma
§ Hepatocellular Carcinoma
§ Lung Cancer
§ Gynecological Cancer
• Type of Treatment
• Type of Immunotherapy
§ Dendritic Cell Vaccine
§ DNA / RNA-based Vaccine
§ Protein / Peptide-based Vaccine
§ TIL-based Therapy
• Route of Administration
• Key Geographical Region
§ North America (US)
§ Europe (UK, Germany, France, Italy, and Spain
§ Rest of the World
§ Transcripts of interviews held with the following senior level representatives of stakeholder companies:
Press Release: Variation 1 (Format 2)
• Gabriel Nistor, Chief Scientific Officer, AIVITA Biomedical
• Ella Sorani, Vice President Research and Development, BioLineRx
• Heinz Lubenau, Chief Operating Officer and Co-Founder, VAXIMM
Key companies covered in the report (https://www.rootsanalysis.com/
§ Bavarian Nordic
§ Genocea Biosciences
§ Immunovative Therapies
§ Iovance Biotherapeutics
§ Neon Therapeutics
§ Precision Biologics
§ Vaxon Biotech
For more information please click on the following link:
Other Recent Offerings
1. T-Cell Immunotherapies Market (4th Edition), 2019-2030 (https://www.rootsanalysis.com/
2. Novel Immuno-Oncology Biomarker Testing Market, 2019-2030
3. Companion Diagnostics Market (2nd Edition), 2019-2030
Roots Analysis Private Limited
+1 (415) 800 3415